IS-001 Injection in Patients Undergoing Robotic-Assisted Colorectal Surgery (NCT07346066)
A Phase 3 Multi-Center Efficacy Study of Filricianine Injection in Patients Undergoing Robotic-Assisted Colorectal Surgery Using the da Vinci Surgical System With Firefly® Fluorescence Imaging
🩺 Plain-English Summary (8th-Grade Level)
This study evaluates the safety and efficacy of intravenous injection of IS-001 to aid in intraoperative ureter structure delineation
Who can join: Review the eligibility criteria below.
Location: Hoag Memorial Hospital Presbyterian — Newport Beach, California
Age range: 16 Years to 75 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (9 Sites)
- Hoag Memorial Hospital Presbyterian — Newport Beach, California
- Yale New Haven Hospital — New Haven, Connecticut
- Orlando Health — Orlando, Florida
- Mountain View Hospital — Las Vegas, Nevada
- The Ohio State Unversity — Columbus, Ohio
- Kettering Health — Kettering, Ohio
- St David's North Austin Medical Center — Austin, Texas
- HCA Houston Healthcare Medical Center — Houston, Texas
- MultiCare Tacoma General Hospital — Tacoma, Washington
📞 Contact the Study Coordinator
Phone: (408) 523-2100
Email: info.is-001@intusurg.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Ureter Injury
- Evaluation of Lumitrace for Visualizing Ureters During Abdominopelvic Surgeries — Kansas City, Missouri
- Indigotindisulfonate Sodium as an Aid in Determination of Ureteral Patency in Patient's With Renal Impairment — Albany, New York
- Indigotindisulfonate Sodium Injection, USP as an Aid in the Determination of Ureteral Patency — Albany, New York
Explore by condition: All Ureter Injury clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.